Status:
ACTIVE_NOT_RECRUITING
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
Lead Sponsor:
Epion Therapeutics
Conditions:
Keratoconus
Eligibility:
All Genders
8-45 years
Phase:
PHASE3
Brief Summary
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With...
Eligibility Criteria
Inclusion
- Diagnosis of keratoconus
Exclusion
- Minimal corneal thickness \< 350 microns
- Non-keratoconic ectatic disease
- Contraindications or hypersensitivities to any required study medications
- Pregnancy or breastfeeding
- Certain concomitant ocular conditions
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06100952
Start Date
November 1 2023
End Date
November 1 2025
Last Update
February 20 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwartz Laser Eye Center
Scottsdale, Arizona, United States, 85260
2
Catalina Eye Center
Tucson, Arizona, United States, 85712
3
Inland Eye Specialists
Murrieta, California, United States, 92562
4
University of Colorado
Aurora, Colorado, United States, 80045